The role of TLR4 in the pathogenesis of indirect acute lung injury

Frontiers in Bioscience

Volumn 18, Issue 4, 2013, Pages 1244-1255

  Hu, Rong ^a   Xu, Hui ^a   Jiang, Hong ^a   Zhang, Ying ^a   Sun, Yu ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Burn injury; IALI; Ischemia reperfusion; LPS; Review; Sepsis; TLR4; Trauma hemorrhage shock

Indexed keywords

EID: 84880555809     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4176     Document Type: Article

References (104)

1. Ware LB, Mattey MA. The acute respiratory distress syndrome. New England Journal of Medicine 342(18), 1334-1349 (2000). (Pubitemid 30408719)
2. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am Journal Respiratory Ritual Care Medicine 149(3Pt1), 818-824 (1994). (Pubitemid 24082248)
3. Zimmerman GA, Albertine KH, Carveth HJ, Gill EA, Grissom CK, Hoidal JR, ImaizumiTA, Maloney CG, McIntyre TM, Michael JR, Orme JF, Prescott SM, Topham MS. Endothelial activation in ARDS. Chest 116(suppl), 18 S-24S (1999).
4. Orfanos SE, Mavrommati I, Korovesi I, Roussos C. Pulmonary endothelium in acute lung injury: from basic science to the critically ill. Intensive Care Med. 30(9), 1702-1714 (2004). (Pubitemid 39297172)
5. Pelosi P, D'Onofrio D, Chiumello D, Paolo S, Chiara G, Capelozzi VL, Barbas CS, Chiaranda M, Gattinoni L. Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl. 42, 48s-56s (2003). (Pubitemid 36975737)
6. Rocco PR, Pelosi P. Pulmonary and extrapulmonary acute respiratory distress syndrome: myth or reality?, Current Opinion in Critical Care 14(1), 50-55 (2008).
7. Xiang M, Fan J. Pattern recognition receptor-dependent mechanisms of acute lung injury. Mol Med. 16(1-2), 69-82 (2010).
8. Perl M, Lomas-Neira J, Venet F, Chung CS, Ayala A. Pathogenesis of indirect (secondary) acute lung injury. Expert Rev Respir Med. 5(1), 115-126 (2011).
9. Baudouin S. Innate immune defense on the attack in acute lung injury. Crit Care Med 38(1), 328-329 (2010).
10. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11(5), 373-384 (2010).
11. Takeda K, Akira S. Toll-like receptors in innate immunity. Int Immunol 17(1), 1-14 (2005).
12. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nature Immunol 2(10), 947- 950 (2001). (Pubitemid 32976167)
13. Noreen M, Shah MA, Mall SM, Choudhary S, Hussain T, Ahmed I, Jalil SF, Raza MI. TLR4 polymorphisms and disease susceptibility. Inflamm Res 61(3), 177-188 (2012).
14. Baumgarten G, Knuefermann P, Wrigge H, Putensen C, Stapel H, Fink K, Meyer R, Hoeft A, Grohé C. Role of Toll-like receptor 4 for the pathogenesis of acutelung injury in Gram-negative sepsis. Eur J Anaesthesiol 23(12), 1041- 1048 (2006). (Pubitemid 44622933)
15. Lorne E, Dupont H, Abraham E. Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? Intensive Care Med 36(11), 1826-1835 (2010).
16. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, Liu H, Sun Y, Pasparakis M, Kopf M, Mech C, Bavari S, Peiris JS, Slutsky AS, Akira S, Hultqvist M, Holmdahi R, Nicholls J, Jiang C, Binder CJ, Penninger JM. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 133(2), 235-249 (2008). (Pubitemid 351512299)
17. Bachmaier K, Toya S, Gao X, Trianttafillou T, Garrean S, Park GY, Frey RS, Vogel S, Minshall R, Christman JW, Tiruppathi C, Malik AB. E3 ubiquitin ligase Cblb regulates the acute inflammatory response underlying lung injury. Nat Med 13(8), 920-926 (2007). (Pubitemid 47222038)
18. Werling D J. O., Offord V, Glass EJ, Coffey TJ. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol. 30, 124-130 (2009).
19. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, Kitamura T, Kosugi A, Kimoto M, Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 3(7), 667-672 (2002). (Pubitemid 34752476)
20. Triantafilou M, Miyake K, Golenbock DT, Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115(Pt12), 2603-2611 (2002). (Pubitemid 34778077)
21. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. MyD88:An adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7(6), 837-847 (1997). (Pubitemid 28064897)
22. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer JL, Di Maro F, French L, Tschopp J. MyD88 an adapter protein involved in interleukin-1 signaling. J Biol Chem 273(20), 12203-12209 (1998). (Pubitemid 28240584)
23. Horng T, Barton GM, Medzhitov R. TIRAP: An adapter molecule in the Toll signaling pathway. Nat Immunol 2(9), 835-841 (2001).
24. Kobayashi K, Hernandez LD, Galán JE, Janeway CA Jr, Medzhitov R, Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110(2), 191- 202 (2002). (Pubitemid 34876547)
25. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. TRAF6 is a signal transducer for interleukin-1. Nature Immunol 383(6599), 443-446 (1996). (Pubitemid 26330834)
26. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4(7), 499-511 (2004). (Pubitemid 38931765)
27. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neil LA. Mal (MyD88-adaptor-like) is required for Toll-like receptor-4 signal transduction. Nature Immunol 413(6851), 78-83 (2001). (Pubitemid 32843491)
28. Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T, Takeda K, Akira S. Essential role of TIRAP for activation of the signaling cascade shared by TLR2 and TLR4. Nature Immunol 420(6913), 324-329 (2002). (Pubitemid 35398188)
29. Horng T, Barton GM, Flavell RA, Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature Immunol 420(6913), 329-333 (2002). (Pubitemid 35398189)
30. Schilling D, Thomas K, Nixdorff K, Vogel SN, Fenton MJ. Toll-like receptor 4 and Toll-IL-1 receptor domaincontaining adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. J Immunol 169(10), 5874-5880 (2002). (Pubitemid 35291692)
31. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11(1), 115-122 (1999). (Pubitemid 29359962)
32. Katsuaki Hoshino, Tsuneyasu K, Tomio I, Osamu T, Shizuo A. Differential involvement of IFN-b in Toll-like receptor-stimulated dendritic cell activation. Int Immunol 14(10), 1225-1231 (2002).
33. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. Role of adaptor TRIF in the MyD88-independent tolllikereceptor signaling pathway. Science(5633) 301, 640- 643 (2003). (Pubitemid 36927946)
34. De Trez C, Pajak B., Brait M, Glaichenhaus N, UrbainJ, Moser M, Lauvau G, Muraille E. TLR4 and Toll- IL-1 receptor domain-containing adapter-inducing IFNbeta, but not MyD88, regulate Escherichia coli-induced dendritic cell maturation and apoptosis in vivo. J Immunol 175(2), 839-846 (2005). (Pubitemid 41094966)
35. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, Akira S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4(11), 1144-1150 (2003). (Pubitemid 37428043)
36. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T. TIR-containing adapter molecule (TICAM)-2: a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-β. J Biol Chem 278(50), 49751-49762 (2003). (Pubitemid 37548808)
37. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4(5), 491-496 (2003). (Pubitemid 36592443)
38. Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, Sanjo H, Kawai T, Hoshino K, Takeda K, Akira S. The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med 199(12), 1641-1650 (2004). (Pubitemid 38821997)
39. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S. A novel TIR domain-containing adaptor that preferentially activates the interferon- βpromoter. J Immunol 169(12), 6668-6672 (2002).
40. Sato S, Suqiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, Akira S. Toll/IL-1 receptor domaincontaining adaptor inducing IFN-β (TRIF) associates with TNF receptorassociated factor 6 and TANKbinding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Tolllike receptor signaling. J Immunol 171(8), 4304-4310 (2003). (Pubitemid 37238709)
41. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M, Tschopp J. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation. Nature Immunol 5(5), 503-507 (2004). (Pubitemid 38660462)
42. O'Neill LA, Fitzgerald KA, Bowie AG. The Toll- IL-1 receptor adaptor family grows to five members. Trends Immunol 24(6), 286-290 (2003).
43. Carty M, Goodbody R, Schröder M, Stack J, Moynagh PN, Bowie AG. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol 7(10), 1074- 1081(2006). (Pubitemid 44420652)
44. Zarember KA, Godowski P. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 168(2), 554-561 (2002). (Pubitemid 34049553)
45. Andonegui G, Bonder CS, Green F, Mullaly SC, Zbytnuik L, Raharjo E, Kubes P. Endothelium-derived tolllike receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs. J Clin Invest 111(7), 1011-1020 (2003). (Pubitemid 36397477)
46. Frink M, Hsieh YC, Thobe BM, Choudhry MA, Schwacha MG, Bland KI, Chaudry IH. TLR4 regulates Kupffer cell chemokine production, systemic inflammation and lung neutrophil infiltration following traumahemorrhage. Mol Immunol 44(10), 2625-2630 (2007). (Pubitemid 46240323)
47. Barsness KA, Arcaroli J, Harken AH, Abraham E, Banerjee A, Reznikov L, McIntyre RC. Hemorrhageinduced acute lung injury is TLR-4 dependent. Am J Physiol Regul Integr Comp Physiol 287(3), R592-R599 (2004). (Pubitemid 39095934)
48. Prince JM, Levy RM, Yang R, Mollen KP, Fink MP, Vodovotz Y, Billiar TR. Toll-like receptor-4 signaling mediates hepatic injury and systemic inflammation in hemorrhagic shock. J Am Coll Surg 202(3), 407-417 (2006). (Pubitemid 43356214)
49. Abraham E. Neutrophils and acute lung injury. Crit Care Med 31(4suppl), S195-S199 (2003). (Pubitemid 36458167)
50. Ayala A, Chung CS, Lomas JL, Song GY, Doughty LA, Gregory SH, Cioffi WG, LeBlanc BW, Reichner J, Simms HH, Grutkoski PS. Shock-Induced Neutrophil Mediated Priming for Acute Lung Injury in Mice. Am J Pathol 161(6), 2283-2294 (2002).
51. Reino DC, Palange D, Feketeova E, Bonitz RP, Xu da Z, Lu Q, Sheth SU, Peña G, Ulloa L, De Maio A, Feinman R, Deitch EA. Activation of toll-like receptor 4 is necessary for trauma hemorrhagic shock-induced gut injury and polymorphonuclear neutrophil priming. Shock 38(1), 107-114 (2012).
52. Lv T, Shen X, Song Y. TLR4 is essential in acute lung injury induced by unresuscitated hemorrhagic shock. J Trauma 66(1), 124-131(2009).
53. Shenkar R, Abraham E. Mechanisms of lung neutrophil activation after hemorrhage or endotoxemia: roles of reactive oxygen intermediates, NF-kappa B, and cyclic AMP response element binding protein. J Immunol 163(2), 954-962 (1999). (Pubitemid 29328107)
54. Behmaou Y, Favre J, Musette P, Renet S, Thuillez C, Richard V, Tamion F. Toll-like receptors 4 contribute to endothelial injury and inflammation in hemorrhagic shock in mice. Crit Care Med 37(5), 1724-1728 (2009).
55. Xiang M, Yin L, Li Y, Xiao G, Vodovotz Y, Billar TR, Wilson MA, Fan J. Hemorrhagic shock activates lung endothelial reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase via neutrophil NADPH oxidase. Am J Respir Cell Mol Biol 44(3), 333-340 (2011).
56. Fan J, Li Y, Vodovotz Y, Billar TR, Wilson MA. Hemorrhagic shock-activated neutrophils augment TLR4 signaling-induced TLR2 upregulation in alveolar macrophages: role in hemorrhage-primed lung inflammation. Am J Physiol Lung Cell Mol Physiol 290(4), L738-L746 (2005). (Pubitemid 43725079)
57. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418(6894), 191-195 (2002). (Pubitemid 34773774)
58. Sha Y, Zmijewski J, Xu Z, Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol 180(4), 2531-2537 (2008).
59. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E. Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 279(9), 7370-7377 (2004). (Pubitemid 38294612)
60. Peltz ED, Moore EE, Eckels PC, Damle SS, Tsuruta Y, Johnson JL, Sauaia A, Silliman CC, Banerjee A, Abraham E. HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans. Shock 32(1), 17-22 (2009).
61. Kim JY, Park JS, Strassheim D, Douglas I, Diaz del Valle F, Asehnoune K, Mitra S, Kwak SH, Yamada S, Maruyama I, Ishizaka A, Abraham E. HMGB1 contributes to the development of acute lung injury after hemorrhage. Am J Physiol Lung Cell Mol Physiol 288(5), 958-965 (2005).
62. Fan J, Li Y, Levy RM, Fan JJ, Hackam DJ, Vodovotz Y, Yang H, Tracey KJ, Billiar TR, Wilson MA. Hemorrhagic shock induces NAD(P)H oxidase activation in neutrophils: role of HMGB1-TLR4 signaling. J Immunol 178(10), 6573- 6580 (2007). (Pubitemid 46717441)
63. McKee CM, Penno MB, Cowman M, Burdick MD, Strieter RM, Bao C, Noble PW (1996) Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The Role of HA size and CD44. J Clin Invest 98(10), 2403-2413 (2007). (Pubitemid 26394217)
64. Taylor KR, Trowbridge JM, Rudisill JA, Termeer CC, Simon JC, Gallo RL Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279(17), 17079-17084 (2004). (Pubitemid 38560463)
65. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, Homer RJ, Goldstein DR, Bucala R, Lee PJ, Medzhitov R, Noble PW. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11(11), 1173-1179 (2005). (Pubitemid 43093664)
66. Taylor KR, Yamasaki K., Radek KA, Di Nardo A, Goodarzi H, Golenbock D, Beutler B, Gallo RL Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J Biol Chem 282(25), 18265- 18275 (2007). (Pubitemid 47100227)
67. Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Puré E, Henson PM, Noble PW. Resolution of lung inflammation by CD44. Science 296(5565), 155-158 (2002). (Pubitemid 34280077)
68. Jack RS, Fan X, Bernheiden M, Rune G, Ehlers M, Weber A, Kirsch G, Mentel R, Fürll B, Freudenberg M, Schmitz G, Stelter F, Schütt C. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 389(6652), 742-745 (1997). (Pubitemid 27458962)
69. Jeyaseelan S, Chu HW, Young SK, Freeman MW, Worthen GS. Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury. Infect Immun 73(3), 1754-1763 (2005). (Pubitemid 40470764)
70. Noulin N, Quesniaux VF, Schnyder-Candrian S, Schnyder B, Maillet I, Robert T, Vargafig BB, Ryffel B, Couillin I. Both hemopoietic and resident cells are required for MyD88-dependent pulmonary inflammatory response to inhaled endotoxin. J Immunol 175(10), 6861-6869 (2005). (Pubitemid 41598931)
71. Schnyder-Candrian S, Quesniaux VF, Di Padova F, Maillet I, Noulin N, Couillin I, Moser R, Erard F, Vargaftig BB, Ryffel B, Schnyder B. Dual effects of p38 MAPK on TNF-dependent bronchoconstriction and TNFindependent neutrophil recruitment in lipopolysaccharideinduced acute respiratory distress syndrome. J Immunol 175(1), 262-269 (2005). (Pubitemid 40884327)
72. Togbe D, Schnyder-Candrian S, Schnyder B, Couillin I, Maillet I, Bihl F, Malo D, Ryffel B, Quesniaux VF. TLR4 gene dosage contributes to endotoxin-induced acute respiratory inflammation. J Leukoc Biol 80(3), 451-457 (2006). (Pubitemid 44835777)
73. Baumgarten G, Knuefermann P, Wrigge H, Putensen C, Stapel H, Fink K, Meyer R, Hoeft A, Grohé C. Role of Tolllike receptor 4 for the pathogenesis of acutelung injury in Gram-negative sepsis. Eur J Anaesthesiol 23(12), 1041-1048 (2006). (Pubitemid 44622933)
74. Pastor CM, Puqin J, Kwak B, Chanson M, Mach F, Hadengue A, Frossard JL Role of Toll-like receptor 4 on pancreatic and pulmonary injury in a mice model of acute pancreatitis associated with endotoxemia. Crit Care Med 32(8), 1759-1763 (2004). (Pubitemid 39050529)
75. Fan J, Malik AB. Toll-like receptor-4 (TLR4) signaling augments chemokine-induced neutrophil migration by modulating cell surface expression of chemokine receptors. Nat Med 9(3), 315-321(2003). (Pubitemid 36362787)
76. Lorne E, Zhao X, Zmijewski JW, Liu G, Park YJ, Tsuruta Y, Abraham E. Participation of mammalian target of rapamycin complex 1 in Toll-like receptor 2- and 4-induced neutrophil activation and acute lung injury. Am J Respir Cell Mol Biol 41(2), 237-245 (2009).
77. Dauphinee SM, Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab Invest 86(1), 9-22 (2006). (Pubitemid 43250964)
78. Andonegui G, Goyert SM, Kubes P. Lipopolysaccharide-induced leukocyte-endothelial cell interactions: a role for CD14 versus toll-like receptor 4 within microvessels. J Immunol 169(4), 2111-2119 (2002). (Pubitemid 34857677)
79. Fan J, Frey RS, Malik AB. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J Clin Invest 112(8), 1234-1243 (2003). (Pubitemid 38056300)
80. dos Santos CC, Han B, Andrade CF, Bai X, Uhlig S, Hubmayr R, Tsang M, Lodyga M, Keshavjee S, Slutsky AS, Liu M. DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFalpha, LPS, and cyclic stretch. Physiol Genomics 19(3), 331-342 (2004).
81. Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, Chignard M, Si-Tahar M. Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem 279(4), 2712-2718 (2004). (Pubitemid 38114260)
82. Skerrett SJ, Liggitt HD, Hajjar AM, Ernst RK, Miller SI, Wilson CB. Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin. Am J Physiol Lung Cell Mol Physiol 287(1), L143-L152 (2004). (Pubitemid 38787661)
83. Perl M, Lomas-Neira J, Chung CS, Ayala A. Epithelial cell apoptosis and neutrophil recruitment in acute lung injury-a unifying hypothesis? What we have learned from small interfering RNAs. MOL Med 14(7-8), 465-475 (2008).
84. Zhai Y, Qiao B, Shen XD, Gao F, Busuttil RW, Cheng G, Platt JL, Volk HD, Kupiec-Weglinski JW. Evidence for the pivotal role of endogenous toll-like receptor 4 ligands in liver ischemia and reperfusion injury. Transplantation 85(7), 1016-1022 (2008). (Pubitemid 351543166)
85. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117(10), 2847-2859 (2007). (Pubitemid 47529615)
86. Chong AJ, Shimamoto A, Hampton CR, Takayama H, Spring DJ, Rothnie CL, Yada M, Pohlman TH, Verrier ED. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 128(2), 170-179 (2004). (Pubitemid 38969797)
87. Shimamoto A, Pohlman TH, Shomura S, Tarukawa T, Takao M, Shimpo H. Toll-like receptor 4 mediates lung ischemia-reperfusion injury. Ann Thorac Surg 82(6), 2017- 2023 (2006).
88. Prakash A, Mesa KR, Wilhelmsen K, Xu F, Dodd-O JM, Hellman J. Alveolar Macrophages and Toll-like Receptor 4 Mediate Ventilated Lung Ischemia Reperfusion Injury in Mice. Anesthesiology 117(4), 1-14 (2012).
89. Soares AL, Coelho FR, Guabiraba R, Kamal M, Vargaftig BB, Li L, Li J, Tavares-de-Lima W, Ryffel B. Tumor necrosis factor is not associated with intestinal ischemia/reperfusion-induced lung inflammation. Shock 34(3), 306-313 (2010).
90. Victoni T, Coelho FR, Soares AL, de Freitas A, Secher T, Guabiraba R, Erard F, de Oliveira-Filho RM, Vargaftig BB, Lauvaux G, Kamal MA, Ryffel B, Moser R, Tavaresde- Lima W. Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway. Med Microbiol Immunol 199(1), 35-42 (2010).
91. Ben DF, Yu XY, Ji GY, Zheng DY, Lv KY, Ma B, Xia ZF. TLR4 mediates lung injury and inflammation in intestinal ischemia-reperfusion. J Surg Res 174(2), 326-333 (2012).
92. den Hengst WA, Gielis JF, Lin JY, Van Schil PE, De Windt LJ, Moens AL Lung ischemia-reperfusion injury: a molecular and clinical view on a complex pathophysiological process. Am J Physiol Heart Circ Physiol 299(5), H1283-H1299 (2010).
93. Shiotani S, Shimada M, Taketomi A, Soejima Y, Yoshizumi T, Hashimoto K, Shimokawa H, Maehara Y. Rho-kinase as a novel gene therapeutic target in treatment of cold ischemia/reperfusion-induced acute lethal liver injury: effect on hepatocellular NADPH oxidase system. Gene Ther 14, 1425-1433 (2007). (Pubitemid 47423742)
94. Lorne E, Zmijewski JW, Zhao X, Liu G, Tsuruta Y, Park YJ, Dupont H, Abraham E. Role of extracellular superoxide in neutrophil activation: interactions between xanthine oxidase and TLR4 induce proinflammatory cytokine production. Am J Physiol Cell Physiol 294(4), C985-C993 (2008). (Pubitemid 351507911)
95. Hartl FU, Hayer-Hartl M. Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295(5561), 1852-1858 (2002). (Pubitemid 34214115)
96. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, Auron PE, Stevenson MA, Calderwood SK. Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4. J Biol Chem 277(17), 15028-15034 (2002). (Pubitemid 34952579)
97. Zou N, Ao L, Cleveland JC Jr, Yang X, Su X, Cai GY, Banerjee A, Fullerton DA, Meng X. Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. Am J Physiol Heart Circ Physiol 294(6), H2805-h2813 (2008).
98. Fernandes TR, Pontieri V, Moretti AI, Teixeira DO, Abatepaulo F, Soriano FG, Negri EM, Velasco IT, Souza HP. Hypertonic saline solution increases the expression of heat shock protein 70 and improves lung inflammation early after reperfusion in a rodent model of controlled hemorrhage. Shock 27(2), 172-178 (2007). (Pubitemid 46105834)
99. Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, Norbury WB, Branski LK, Gauglitz GG, Mlcak RP, Herndon DN. Pathophysiologic response to severe burn injury. Ann Surg 248(3), 387-401(2008).
100. Ipaktchi K, Mattar A, Niederbichler AD, Kim J, Hoesel LM, Hemmila MR, Su GL, Remick DG, Wang SC, Arbabi S. Attenuating burn wound inflammation improves pulmonary function and survival in a burn-pneumonia model. Crit Care Med 35(9), 2139-2144 (2007). (Pubitemid 47326451)
101. Peterson CY, Costantini TW, Loomis WH, Putnam JG, Wolf P, Bansal V, Eliceiri BP, Baird A, Coimbra R. Toll-like receptor-4 mediates intestinal barrier breakdown after thermal injury. Surg Infect (Larchmt) 11(2), 137-144 (2010).
102. Breslin JW, Wu MH, Guo M, Reynoso R, Yuan SY. Toll-like receptor 4 contributes to microvascular inflammation and barrier dysfunction in thermal injury. Shock 29(3), 349-355 (2008). (Pubitemid 351271706)
103. Krzyzaniak M, Cheadle G, Peterson C, Loomis W, Putnam J, Wolf P, Baird A, Eliceiri B, Bansal V, Coimbra R. Burn-induced acute lung injury requires a functional Toll-like receptor 4. Shock 36(1), 24-29 (2011).
104. Oppeltz RF, Rani M, Zhang Q, Schwacha MG. Burninduced alterations in toll-like receptor-mediated responses by bronchoalveolar lavage cells. Cytokine 55(3), 396- 401(2011).